Cargando…

Clinical significance of IFIT2 expression in human renal cancer tissues

BACKGROUND: Interferon (IFN)-induced protein with tetratricopeptide repeats 2 (IFIT2) is an important member of the IFN-stimulated gene (ISG) family. It has been demonstrated that IFIT2 is important in the physiopathological processes of antiviral and antitumor activities. We previously demonstrated...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Bin, Zhu, Yu-Lan, Fan, Jia-Lin, Chen, Lu-Jun, Jiang, Jing-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797327/
https://www.ncbi.nlm.nih.gov/pubmed/35117687
http://dx.doi.org/10.21037/tcr.2020.04.10
_version_ 1784641523889995776
author Xu, Bin
Zhu, Yu-Lan
Fan, Jia-Lin
Chen, Lu-Jun
Jiang, Jing-Ting
author_facet Xu, Bin
Zhu, Yu-Lan
Fan, Jia-Lin
Chen, Lu-Jun
Jiang, Jing-Ting
author_sort Xu, Bin
collection PubMed
description BACKGROUND: Interferon (IFN)-induced protein with tetratricopeptide repeats 2 (IFIT2) is an important member of the IFN-stimulated gene (ISG) family. It has been demonstrated that IFIT2 is important in the physiopathological processes of antiviral and antitumor activities. We previously demonstrated that IFIT2 was highly expressed in paracarcinoma tissues compared with gastric cancer tissues, and its expression level was positively correlated with a superior postoperative prognosis of the patients. METHODS: We performed immunohistochemical staining of IFIT2 in human clear cell renal cell carcinoma (ccRCC) tissues by using a tissue microarray. RNAseq data of kidney clear cell carcinoma (KIRC) samples from The Cancer Genome Atlas (TCGA) were used to perform the enrichment analyses based on the genes that were highly correlated with IFIT2. RESULTS: Weak staining of IFIT2 was located on the cytoplasm and cell membrane surface of the cancer cells, while positive staining of IFIT2 was located mainly on adjacent normal tissues. Survival analysis showed that patients with higher IFIT2 expression had better overall survival than patients with lower IFIT2 expression (P=0.030). The Cox model further demonstrated that age (P=0.002), pathological stage (P=0.000), TNM stage (P=0.005) and IFIT2 expression (P=0.003) could be used as independent prognostic predictors for ccRCC patients. Additionally, the enrichment analysis based on ccRCC expression profile data extracted from TCGA revealed that the genes highly correlated with IFIT2 were mainly related to the biological processes of virus response, T cells and the innate immune response (GO:0009615, GO:0042110, and GO:0045088) and the pathways of NLR signaling, chemokine signaling, and TLR signaling (hsa04621, hsa04062, and hsa04620). CONCLUSIONS: IFIT2 could serve as a potential prognostic marker for ccRCC patients, and the mechanism of decreased IFIT2 expression in the progression of ccRCC merits further investigation.
format Online
Article
Text
id pubmed-8797327
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87973272022-02-02 Clinical significance of IFIT2 expression in human renal cancer tissues Xu, Bin Zhu, Yu-Lan Fan, Jia-Lin Chen, Lu-Jun Jiang, Jing-Ting Transl Cancer Res Original Article BACKGROUND: Interferon (IFN)-induced protein with tetratricopeptide repeats 2 (IFIT2) is an important member of the IFN-stimulated gene (ISG) family. It has been demonstrated that IFIT2 is important in the physiopathological processes of antiviral and antitumor activities. We previously demonstrated that IFIT2 was highly expressed in paracarcinoma tissues compared with gastric cancer tissues, and its expression level was positively correlated with a superior postoperative prognosis of the patients. METHODS: We performed immunohistochemical staining of IFIT2 in human clear cell renal cell carcinoma (ccRCC) tissues by using a tissue microarray. RNAseq data of kidney clear cell carcinoma (KIRC) samples from The Cancer Genome Atlas (TCGA) were used to perform the enrichment analyses based on the genes that were highly correlated with IFIT2. RESULTS: Weak staining of IFIT2 was located on the cytoplasm and cell membrane surface of the cancer cells, while positive staining of IFIT2 was located mainly on adjacent normal tissues. Survival analysis showed that patients with higher IFIT2 expression had better overall survival than patients with lower IFIT2 expression (P=0.030). The Cox model further demonstrated that age (P=0.002), pathological stage (P=0.000), TNM stage (P=0.005) and IFIT2 expression (P=0.003) could be used as independent prognostic predictors for ccRCC patients. Additionally, the enrichment analysis based on ccRCC expression profile data extracted from TCGA revealed that the genes highly correlated with IFIT2 were mainly related to the biological processes of virus response, T cells and the innate immune response (GO:0009615, GO:0042110, and GO:0045088) and the pathways of NLR signaling, chemokine signaling, and TLR signaling (hsa04621, hsa04062, and hsa04620). CONCLUSIONS: IFIT2 could serve as a potential prognostic marker for ccRCC patients, and the mechanism of decreased IFIT2 expression in the progression of ccRCC merits further investigation. AME Publishing Company 2020-05 /pmc/articles/PMC8797327/ /pubmed/35117687 http://dx.doi.org/10.21037/tcr.2020.04.10 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Xu, Bin
Zhu, Yu-Lan
Fan, Jia-Lin
Chen, Lu-Jun
Jiang, Jing-Ting
Clinical significance of IFIT2 expression in human renal cancer tissues
title Clinical significance of IFIT2 expression in human renal cancer tissues
title_full Clinical significance of IFIT2 expression in human renal cancer tissues
title_fullStr Clinical significance of IFIT2 expression in human renal cancer tissues
title_full_unstemmed Clinical significance of IFIT2 expression in human renal cancer tissues
title_short Clinical significance of IFIT2 expression in human renal cancer tissues
title_sort clinical significance of ifit2 expression in human renal cancer tissues
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797327/
https://www.ncbi.nlm.nih.gov/pubmed/35117687
http://dx.doi.org/10.21037/tcr.2020.04.10
work_keys_str_mv AT xubin clinicalsignificanceofifit2expressioninhumanrenalcancertissues
AT zhuyulan clinicalsignificanceofifit2expressioninhumanrenalcancertissues
AT fanjialin clinicalsignificanceofifit2expressioninhumanrenalcancertissues
AT chenlujun clinicalsignificanceofifit2expressioninhumanrenalcancertissues
AT jiangjingting clinicalsignificanceofifit2expressioninhumanrenalcancertissues